New Biotech, Synaptix, launched to develop treatment for Tubb4a H-abc!
Very exciting news for the H-abc community. Biotech Synaptix has launched and are working hard to develop ASO gene therapy for H-abc and Tubb4a. Click on their website below to learn more.
Writesonic's feature set overlaps with several email tasks, but the details decide whether it fits your workflow. This context breakdown reviews its applicability for drafting, replying, polishing, marketing, and outreach, along with the trade-offs to expect.
The pitch here centers on combining premium publishers with high-value advertisers, which is a common but tricky balance to get right. The JZZ Media platform seems built around that pairing, so it may be worth a look for regional campaign planning.